Put Options

8 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2022

May 17, 2022

SELL
$31.97 - $41.06 $262,154 - $336,692
-8,200 Reduced 30.94%
18,300 $730,000
Q4 2021

Feb 15, 2022

BUY
$31.82 - $40.75 $292,744 - $374,900
9,200 Added 53.18%
26,500 $1.07 Million
Q3 2021

Nov 16, 2021

BUY
$38.47 - $46.42 $230,820 - $278,520
6,000 Added 53.1%
17,300 $704,000
Q2 2021

Aug 16, 2021

SELL
$38.84 - $51.31 $34,956 - $46,179
-900 Reduced 7.38%
11,300 $513,000
Q1 2021

May 18, 2021

SELL
$39.51 - $51.45 $181,746 - $236,670
-4,600 Reduced 27.38%
12,200 $509,000
Q4 2020

Feb 17, 2021

BUY
$25.81 - $43.62 $103,240 - $174,480
4,000 Added 31.25%
16,800 $718,000
Q3 2020

Nov 17, 2020

SELL
$25.74 - $29.63 $445,302 - $512,599
-17,300 Reduced 57.48%
12,800 $336,000
Q2 2020

Aug 17, 2020

BUY
$16.25 - $26.81 $489,125 - $806,981
30,100 New
30,100 $807,000

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $8.49B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.